Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

BACKGROUND: Levamisole has shown clinical benefits in the management of COVID-19 via its immunomodulatory effect. However, the exact role of Levamisole effect in clinical status of COVID-19 patients is unknown. We aimed to evaluate the efficacy of Levamisole on clinical status of patients with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Roostaei Firozabad, Amirreza, Meybodi, Zohreh Akhoundi, Mousavinasab, Seyed Ruhollah, Sahebnasagh, Adeleh, Jelodar, Mohsen Gholinataj, Karimzadeh, Iman, Habtemariam, Solomon, Saghafi, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988635/
https://www.ncbi.nlm.nih.gov/pubmed/33761870
http://dx.doi.org/10.1186/s12879-021-05983-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988635/
https://www.ncbi.nlm.nih.gov/pubmed/33761870
http://dx.doi.org/10.1186/s12879-021-05983-2

Ejemplares similares